Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke(University Medical Center Freiburg), Wolfgang Bethge(Universitätsklinikum Tübingen), Claudia Schmoor(University Medical Center Freiburg), Hellmut Ottinger(Essen University Hospital), Matthias Stelljes(University Hospital Münster), Axel R. Zander(Universität Hamburg), Liisa Volin(Helsinki University Hospital), Tapani Ruutu(Helsinki University Hospital), Dominik Heim(University Hospital of Basel), Rainer Schwerdtfeger(Deutsche Klinik für Diagnostik), Karin Kolbe(University Medical Center of the Johannes Gutenberg University Mainz), Jiřı́ Mayer(University Hospital Brno), Johan Maertens(Universitair Ziekenhuis Leuven), Werner Linkesch(Graz University Hospital), Ernst Holler(University of Regensburg), Vladimír Koza(University Hospital Plzen), Martin Bornhäuser(University Hospital Carl Gustav Carus), Hermann Einsele, Hans‐Jochem Kolb, Hartmut Bertz, Matthias Egger, Olga Grishina(University Medical Center Freiburg), Gèrard Socié(Hôpital Saint-Louis)
The Lancet Oncology
August 19, 2009
Cited by 717

Abstract


Related Papers

No related papers found

Powered by citation graph analysis